Illumina | Sequencing and array solutions to fuel genomic …
Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.
Illumina, Inc. - Wikipedia
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.
Careers | Biotech and genomics job opportunities - Illumina
At Illumina, we have the opportunity to do work that transforms human health. Find genomics and biotech jobs at Illumina.
Illumina, Inc. - Illumina and NVIDIA collaborate to decode …
Jan 13, 2025 · Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance technology platforms for the analysis and interpretation of multiomic data, accelerating progress in clinical research, genomics AI development, and drug discovery.
All Products - Illumina, Inc.
View a complete list of Illumina sequencing and microarray products. Filter by system compatibility and other key features to narrow the list.
25 greatest impacts in 25 years: Illumina and the evolution of …
Apr 3, 2023 · Illumina, a global leader in DNA sequencing and array-based technologies, celebrates its 25th year in business. For our anniversary, we’re counting the ways our technology has changed health care and the environment
Company Overview | An innovative genomics company - Illumina…
Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.
Illumina, Inc. - Illumina acquires Fluent BioSciences to accelerate ...
Jul 9, 2024 · Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced that effective today it has acquired Fluent BioSciences, developer of an emerging and highly differentiated single-cell technology.
Illumina, Inc. - Illumina introduces the MiSeq i100 Series: its ...
Oct 9, 2024 · Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today unveiled its MiSeq™ i100 Series of sequencing systems, delivering unparalleled benchtop speed and simplicity to advance …
Products for Genomics | Illumina
Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.